Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Reneuron Group Plc (RENE.LN)

Reneuron Group Plc (RENE.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Reneuron Group Plc Pencoed Business Park Pencoed Bridgend CF35 5HY GBR

https://www.reneuron.com P: 203-819-8400

Description:

ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.

Key Statistics

Overview:

Market Capitalization, $K 1,930
Shares Outstanding, K 57,174
Annual Sales, $ 530 K
Annual Net Income, $ -5,408 K
% of Insider Shareholders 13.81%
% of Institutional Shareholders 12.59%

Growth:

1-Year Return -69.66%
3-Year Return -97.36%
5-Year Return -93.45%
5-Year Revenue Growth 65.26%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.09
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 01/24/18

RENE.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 0.47
Return-on-Equity % -106.77%
Return-on-Assets % -50.10%
Profit Margin % -1,020.38%
Debt/Equity 0.05
Price/Sales 7.75
Price/Book 0.80
Book Value/Share 0.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar